TY - JOUR
T1 - Endovascular thrombectomy for acute ischaemic stroke with established large infarct
T2 - multicentre, open-label, randomised trial
AU - TENSION Investigators
AU - Bendszus, Martin
AU - Bonekamp, Susanne
AU - Herweh, Christian
AU - Möhlenbruch, Markus
AU - Ulfert, Christian
AU - Vollherbst, Dominik F.
AU - Ringleb, Peter Arthur
AU - Schönenberger, Silvia
AU - Wick, Wolfgang
AU - Fiehler, Jens
AU - Flottmann, Fabian
AU - Gellißen, Susanne
AU - Cheng, Bastian
AU - Jensen, Märit
AU - Schell, Maximilian
AU - Schlemm, Eckhard
AU - Thomalla, Götz
AU - Subtil, Fabien
AU - Denis, Angélique
AU - Subtil, Fabien
AU - Denis, Angélique
AU - Aamodt, Anne Hege
AU - Tennøe, Bjørn
AU - Fuentes, Blanca
AU - Gizewski, Elke R.
AU - Hill, Michael D.
AU - Goyal, Mayank
AU - Krajina, Antonin
AU - Raupach, Jan
AU - Vítková, Eva
AU - Pierot, Laurent
AU - Pagano, Paolo
AU - Hua, Vi Tuan
AU - Simonsen, Claus Z.
AU - Blauenfeldt, Rolf A.
AU - Mikkelsen, Ronni
AU - Zeleňák, Kamil
AU - Kurča, Egon
AU - Deutschmann, Hannes
AU - Dorn, Franziska
AU - Gerber, Johannes C.
AU - Puetz, Volker
AU - Gerber, Johannes C.
AU - Puetz, Volker
AU - Haring, Jozef
AU - Klepanec, Andrej
AU - Hopf-Jensen, Silke
AU - Müller-Hülsbeck, Stefan
AU - Kastrup, Andreas
AU - Papanagiotou, Panagiotis
N1 - Publisher Copyright:
© 2023 Elsevier Ltd
PY - 2023/11/11
Y1 - 2023/11/11
N2 - Background: Recent evidence suggests a beneficial effect of endovascular thrombectomy in acute ischaemic stroke with large infarct; however, previous trials have relied on multimodal brain imaging, whereas non-contrast CT is mostly used in clinical practice. Methods: In a prospective multicentre, open-label, randomised trial, patients with acute ischaemic stroke due to large vessel occlusion in the anterior circulation and a large established infarct indicated by an Alberta Stroke Program Early Computed Tomographic Score (ASPECTS) of 3–5 were randomly assigned using a central, web-based system (using a 1:1 ratio) to receive either endovascular thrombectomy with medical treatment or medical treatment (ie, standard of care) alone up to 12 h from stroke onset. The study was conducted in 40 hospitals in Europe and one site in Canada. The primary outcome was functional outcome across the entire range of the modified Rankin Scale at 90 days, assessed by investigators masked to treatment assignment. The primary analysis was done in the intention-to-treat population. Safety endpoints included mortality and rates of symptomatic intracranial haemorrhage and were analysed in the safety population, which included all patients based on the treatment they received. This trial is registered with ClinicalTrials.gov, NCT03094715. Findings: From July 17, 2018, to Feb 21, 2023, 253 patients were randomly assigned, with 125 patients assigned to endovascular thrombectomy and 128 to medical treatment alone. The trial was stopped early for efficacy after the first pre-planned interim analysis. At 90 days, endovascular thrombectomy was associated with a shift in the distribution of scores on the modified Rankin Scale towards better outcome (adjusted common OR 2·58 [95% CI 1·60–4·15]; p=0·0001) and with lower mortality (hazard ratio 0·67 [95% CI 0·46–0·98]; p=0·038). Symptomatic intracranial haemorrhage occurred in seven (6%) patients with thrombectomy and in six (5%) with medical treatment alone. Interpretation: Endovascular thrombectomy was associated with improved functional outcome and lower mortality in patients with acute ischaemic stroke from large vessel occlusion with established large infarct in a setting using non-contrast CT as the predominant imaging modality for patient selection. Funding: EU Horizon 2020.
AB - Background: Recent evidence suggests a beneficial effect of endovascular thrombectomy in acute ischaemic stroke with large infarct; however, previous trials have relied on multimodal brain imaging, whereas non-contrast CT is mostly used in clinical practice. Methods: In a prospective multicentre, open-label, randomised trial, patients with acute ischaemic stroke due to large vessel occlusion in the anterior circulation and a large established infarct indicated by an Alberta Stroke Program Early Computed Tomographic Score (ASPECTS) of 3–5 were randomly assigned using a central, web-based system (using a 1:1 ratio) to receive either endovascular thrombectomy with medical treatment or medical treatment (ie, standard of care) alone up to 12 h from stroke onset. The study was conducted in 40 hospitals in Europe and one site in Canada. The primary outcome was functional outcome across the entire range of the modified Rankin Scale at 90 days, assessed by investigators masked to treatment assignment. The primary analysis was done in the intention-to-treat population. Safety endpoints included mortality and rates of symptomatic intracranial haemorrhage and were analysed in the safety population, which included all patients based on the treatment they received. This trial is registered with ClinicalTrials.gov, NCT03094715. Findings: From July 17, 2018, to Feb 21, 2023, 253 patients were randomly assigned, with 125 patients assigned to endovascular thrombectomy and 128 to medical treatment alone. The trial was stopped early for efficacy after the first pre-planned interim analysis. At 90 days, endovascular thrombectomy was associated with a shift in the distribution of scores on the modified Rankin Scale towards better outcome (adjusted common OR 2·58 [95% CI 1·60–4·15]; p=0·0001) and with lower mortality (hazard ratio 0·67 [95% CI 0·46–0·98]; p=0·038). Symptomatic intracranial haemorrhage occurred in seven (6%) patients with thrombectomy and in six (5%) with medical treatment alone. Interpretation: Endovascular thrombectomy was associated with improved functional outcome and lower mortality in patients with acute ischaemic stroke from large vessel occlusion with established large infarct in a setting using non-contrast CT as the predominant imaging modality for patient selection. Funding: EU Horizon 2020.
UR - https://www.scopus.com/pages/publications/85175870744
U2 - 10.1016/S0140-6736(23)02032-9
DO - 10.1016/S0140-6736(23)02032-9
M3 - Artículo
C2 - 37837989
AN - SCOPUS:85175870744
SN - 0140-6736
VL - 402
SP - 1753
EP - 1763
JO - The Lancet
JF - The Lancet
IS - 10414
ER -